Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minji K Uh

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 30, 2013
Evaluating tumor angiogenesisMinji K Uh, Jessica Kandel, Jan Kitajewski
Scientific Reports|November 14, 2015
Combined deficiency of Notch1 and Notch3 causes pericyte dysfunction, models CADASIL, and results in arteriovenous malformationsNatalie M Kofler, Henar Cuervo, Minji K Uh, et al.
Development (Cambridge, England)|June 12, 2014
Notch signaling functions in lymphatic valve formationAino Murtomaki, Minji K Uh, Chris Kitajewski, et al.
Development (Cambridge, England)|April 26, 2013
Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endotheliumAino Murtomaki, Minji K Uh, Yun K Choi, et al.
JTO Clinical and Research Reports|June 26, 2025
Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in <i>RET</i> Fusion-Positive NSCLCCaicun Zhou, Silvia Novello, Pilar Garrido, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
CNS Protective Effect of Selpercatinib in First-Line <i>RET</i> Fusion-Positive Advanced Non-Small Cell Lung CancerMaurice Pérol, Benjamin J Solomon, Koichi Goto, et al.
The New England Journal of Medicine|October 23, 2023
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in <i>RET</i> Fusion-Positive NSCLCCaicun Zhou, Benjamin Solomon, Herbert H Loong, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|January 30, 2013
Evaluating tumor angiogenesisMinji K Uh, Jessica Kandel, Jan Kitajewski
Scientific Reports|November 14, 2015
Combined deficiency of Notch1 and Notch3 causes pericyte dysfunction, models CADASIL, and results in arteriovenous malformationsNatalie M Kofler, Henar Cuervo, Minji K Uh, et al.
Development (Cambridge, England)|June 12, 2014
Notch signaling functions in lymphatic valve formationAino Murtomaki, Minji K Uh, Chris Kitajewski, et al.
Development (Cambridge, England)|April 26, 2013
Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endotheliumAino Murtomaki, Minji K Uh, Yun K Choi, et al.
JTO Clinical and Research Reports|June 26, 2025
Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in <i>RET</i> Fusion-Positive NSCLCCaicun Zhou, Silvia Novello, Pilar Garrido, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
CNS Protective Effect of Selpercatinib in First-Line <i>RET</i> Fusion-Positive Advanced Non-Small Cell Lung CancerMaurice Pérol, Benjamin J Solomon, Koichi Goto, et al.
The New England Journal of Medicine|October 23, 2023
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in <i>RET</i> Fusion-Positive NSCLCCaicun Zhou, Benjamin Solomon, Herbert H Loong, et al.
Pageof 1